carmustine has been researched along with Cell Transformation, Neoplastic in 16 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (62.50) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riolobos, L | 1 |
| Gad, EA | 1 |
| Treuting, PM | 1 |
| Timms, AE | 1 |
| Hershberg, EA | 1 |
| Corulli, LR | 1 |
| Rodmaker, E | 1 |
| Disis, ML | 1 |
| Ghosh, M | 1 |
| Dwyer-Nield, LD | 1 |
| Kwon, JB | 1 |
| Barthel, L | 1 |
| Janssen, WJ | 1 |
| Merrick, DT | 1 |
| Keith, RL | 1 |
| Darby Weydert, CJ | 1 |
| Smith, BB | 1 |
| Xu, L | 1 |
| Kregel, KC | 1 |
| Ritchie, JM | 1 |
| Davis, CS | 1 |
| Oberley, LW | 1 |
| Milojković, D | 1 |
| Aldouri, M | 1 |
| Pagliuca, A | 1 |
| Mufti, GJ | 1 |
| Devereux, S | 1 |
| Salmon, SE | 3 |
| Erickson, LC | 3 |
| Zlotogorski, C | 1 |
| Drago, JR | 1 |
| Worgul, TJ | 1 |
| Gallagher, C | 1 |
| Hofmann, V | 1 |
| Durie, BG | 2 |
| Bradley, MO | 2 |
| Kohn, KW | 2 |
| Hamburger, AW | 1 |
| Bonmassar, E | 1 |
| Houchens, DP | 1 |
| Fioretti, MC | 1 |
| Goldin, A | 1 |
| von Hofe, E | 1 |
| Kennedy, AR | 1 |
| Thomale, J | 1 |
| Huh, NH | 1 |
| Nehls, P | 1 |
| Eberle, G | 1 |
| Rajewsky, MF | 1 |
| Komatsu, K | 1 |
| Miller, RC | 1 |
| Hall, EJ | 1 |
| Holland, JF | 1 |
| Glidewell, O | 1 |
1 trial available for carmustine and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Chemotherapy of acute lymphocytic leukemia of childhood.
Topics: Adolescent; Adult; Antineoplastic Agents; Asparaginase; Carmustine; Cell Division; Cell Transformati | 1972 |
15 other studies available for carmustine and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
The Effect of Mouse Strain, Sex, and Carcinogen Dose on Toxicity and the Development of Lung Dysplasia and Squamous Cell Carcinomas in Mice.
Topics: Animals; Carcinogens; Carcinoma, Squamous Cell; Carmustine; Cell Transformation, Neoplastic; Dose-Re | 2019 |
Tracheal dysplasia precedes bronchial dysplasia in mouse model of N-nitroso trischloroethylurea induced squamous cell lung cancer.
Topics: Animals; Biomarkers, Tumor; Bronchi; Carcinoma, Squamous Cell; Carmustine; Cell Transformation, Neop | 2015 |
Inhibition of oral cancer cell growth by adenovirusMnSOD plus BCNU treatment.
Topics: Adenoviridae; Animals; Antioxidants; Carmustine; Catalase; Cattle; Cell Division; Cell Transformatio | 2003 |
Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy.
Topics: Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Muri | 2006 |
In vitro cloning and chemosensitivity of human myeloma stem cells.
Topics: Animals; Carmustine; Cell Transformation, Neoplastic; Clone Cells; Colony-Forming Units Assay; DNA; | 1982 |
Induction and repair of macromolecular damage by alkylating agents.
Topics: Animals; Carmustine; Cell Line; Cell Transformation, Neoplastic; Cell Transformation, Viral; Colony- | 1984 |
Castration--chemotherapy treatment of prostate cancer model.
Topics: Animals; Carmustine; Castration; Cell Transformation, Neoplastic; Cisplatin; Cyclophosphamide; Disea | 1981 |
Drug resistance in multiple myeloma associated with high in vitro incorporation of 3H-thymidine.
Topics: Carmustine; Cell Nucleus; Cell Transformation, Neoplastic; Doxorubicin; Drug Resistance; Drug Therap | 1981 |
Strand breaks in DNA from normal and transformed human cells treated with 1,3-bis(2-chloroethyl)-1-nitrosourea.
Topics: Alkalies; Carmustine; Cell Transformation, Neoplastic; Cells, Cultured; Centrifugation, Density Grad | 1977 |
Differential inhibition of the rejoining of X-ray-induced DNA strand breaks in normal and transformed human fibroblasts treated with 1,3-bis(2-chloroethyl)-1-nitrosourea in vitro.
Topics: Carmustine; Cell Survival; Cell Transformation, Neoplastic; Cells, Cultured; DNA Repair; DNA, Neopla | 1978 |
A new basis for treatment of multiple myeloma.
Topics: Carmustine; Cell Transformation, Neoplastic; Doxorubicin; Drug Resistance; Humans; Melphalan; Multip | 1978 |
Uptake of 5-iododeoxyuridine as a measure of tumor growth and tumor inhibition.
Topics: Animals; Carmustine; Cell Transformation, Neoplastic; Cyclophosphamide; DNA, Neoplasm; Female; Idoxu | 1975 |
X-ray induction of O6-alkylguanine-DNA alkyltransferase protects against some of the biological effects of N-methyl-N'-nitro-N-nitrosoguanidine in C3H 10T1/2 cells.
Topics: Animals; Carmustine; Cell Survival; Cell Transformation, Neoplastic; Cells, Cultured; DNA Damage; En | 1991 |
Repair of O6-ethylguanine in DNA protects rat 208F cells from tumorigenic conversion by N-ethyl-N-nitrosourea.
Topics: Animals; Carmustine; Cell Line; Cell Survival; Cell Transformation, Neoplastic; Clone Cells; DNA; DN | 1990 |
The oncogenic potential of a combination of hyperthermia and chemotherapy agents.
Topics: Animals; Carmustine; Cell Survival; Cell Transformation, Neoplastic; Dactinomycin; Dose-Response Rel | 1988 |